Correlation Between Singular Genomics and Consorcio ARA

Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Consorcio ARA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Consorcio ARA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Singular Genomics Systems and Consorcio ARA S, you can compare the effects of market volatilities on Singular Genomics and Consorcio ARA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Consorcio ARA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Consorcio ARA.

Diversification Opportunities for Singular Genomics and Consorcio ARA

-0.45

Correlation Coefficient

Singular Genomics  Consorcio ARA

Very good diversification

The 3 months correlation between Singular and Consorcio is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Consorcio ARA S in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Consorcio ARA S and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Consorcio ARA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Consorcio ARA S has no effect on the direction of Singular Genomics i.e., Singular Genomics and Consorcio ARA go up and down completely randomly.

Pair Corralation between Singular Genomics and Consorcio ARA

Given the investment horizon of 90 days Singular Genomics Systems is expected to generate 1.6 times more return on investment than Consorcio ARA. However, Singular Genomics is 1.6 times more volatile than Consorcio ARA S. It trades about 0.17 of its potential returns per unit of risk. Consorcio ARA S is currently generating about -0.01 per unit of risk. If you would invest  616.00  in Singular Genomics Systems on September 4, 2024 and sell it today you would earn a total of  1,555  from holding Singular Genomics Systems or generate 252.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Singular Genomics Systems  vs.  Consorcio ARA S

Singular Genomics Systems

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Consorcio ARA S

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Consorcio ARA S has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Singular Genomics and Consorcio ARA

The main advantage of trading using opposite Singular Genomics and Consorcio ARA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Consorcio ARA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Consorcio ARA will offset losses from the drop in Consorcio ARA's long position.

The idea behind Singular Genomics Systems and Consorcio ARA S pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.